• Noctrix Health: Wearable Therapeutics For RLS

  • 2024/05/28
  • 再生時間: 39 分
  • ポッドキャスト

Noctrix Health: Wearable Therapeutics For RLS

  • サマリー

  • Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health. Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS). This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S. A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a number of associated negative side effects. Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

    Resources & Links
    LinkedIn: Mike Moore
    LinkedIn: The Bleeding Edge of Digital Health

    続きを読む 一部表示

あらすじ・解説

Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health. Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS). This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S. A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a number of associated negative side effects. Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

activate_samplebutton_t1

Noctrix Health: Wearable Therapeutics For RLSに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。